We continuously invest in R&D and expand our scientific research team to drive innovation. Our R&D pipeline focuses on developing cutting-edge biotechnological solutions, including BIO-APIs, recombinant bioreagents and therapeutic peptides. We prioritize projects with significant potential to enhance product quality and efficiency, ensuring they meet stringent regulatory standards and market demands.